How can AI determine who gets matched to new therapies, who is identified for clinical trials, and how patient tracking is scaled across large populations? Chip is joined by Dr. A.J. Blood, a practicing cardiologist at Brigham and Women’s Hospital and the co-founder and Chief Executive Officer of AIwithCare, a startup company that delivers AI-enabled solutions for research, clinical operations, and patient care. They discuss the role of AI in identifying patients for clinical trials and new therapies—which is typically a critical bottleneck in drug development—as well as how to ensure clinical trials are representative. Also, Dr. Blood shares insights from his extensive research background and the tool, RECTIFIER (RAG-Enabled Clinical Trial Infrastructure for Inclusion Exclusion Review), designed to enhance patient recruitment for clinical trials by efficiently sifting through complex medical data.
Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging – Business Wire
Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging Business Wire
